Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Update    entities : Arbutus biopharma corporation    save search

Barinthus Bio Reports Full Year 2023 Financial Results and Update on Corporate Developments
Published: 2024-03-20 (Crawled : 12:00) - globenewswire.com
ABUS | $2.99 2.75% 2.68% 3.6M twitter stocktwits trandingview |
Health Technology
| | O: -1.58% H: 3.05% C: 2.41%

year update financial results
Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update
Published: 2024-02-29 (Crawled : 12:30) - globenewswire.com
ROIV | $10.85 -0.82% -0.83% 4.7M twitter stocktwits trandingview |
Manufacturing
| | O: 1.2% H: 0.34% C: -3.46%
ABUS | $2.99 2.75% 2.68% 3.6M twitter stocktwits trandingview |
Health Technology
| | O: -1.37% H: 0.0% C: -2.44%

year update financial results
Arbutus to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update
Published: 2024-02-15 (Crawled : 12:30) - globenewswire.com
ABUS | $2.99 2.75% 2.68% 3.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.85% H: 0.0% C: -1.36%

report year update financial results
Arbutus Announces 2024 Corporate Objectives and Provides Financial Update
Published: 2024-01-08 (Crawled : 13:00) - globenewswire.com
ABUS | $2.99 2.75% 2.68% 3.6M twitter stocktwits trandingview |
Health Technology
| | O: 3.32% H: 3.21% C: -1.61%

update financial
Arbutus Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-11-07 (Crawled : 13:00) - globenewswire.com
ROIV | $10.85 -0.82% -0.83% 4.7M twitter stocktwits trandingview |
Manufacturing
| | O: 0.56% H: 2.68% C: 1.68%
ABUS | $2.99 2.75% 2.68% 3.6M twitter stocktwits trandingview |
Health Technology
| | O: -4.76% H: 0.0% C: 0.0%

update financial results
Arbutus to Report Third Quarter 2023 Financial Results and Provide Corporate Update
Published: 2023-10-24 (Crawled : 12:00) - globenewswire.com
ABUS | $2.99 2.75% 2.68% 3.6M twitter stocktwits trandingview |
Health Technology
| | O: -1.73% H: 4.71% C: 4.12%

report update financial results
Arbutus Reports Second Quarter 2023 Financial Results and Corporate Update
Published: 2023-08-03 (Crawled : 12:00) - globenewswire.com
ROIV | $10.85 -0.82% -0.83% 4.7M twitter stocktwits trandingview |
Manufacturing
| | O: -0.51% H: 2.13% C: -2.13%
ABUS | $2.99 2.75% 2.68% 3.6M twitter stocktwits trandingview |
Health Technology
| | O: 1.43% H: 0.0% C: -3.29%

update financial results
Arbutus to Report Second Quarter 2023 Financial Results and Provide Corporate Update
Published: 2023-07-20 (Crawled : 12:00) - globenewswire.com
ABUS | $2.99 2.75% 2.68% 3.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.44% C: -0.44%

report update financial results
Arbutus Reports First Quarter 2023 Financial Results and Corporate Update
Published: 2023-05-04 (Crawled : 11:00) - globenewswire.com
BNTX | $87.88 1.62% 1.59% 750K twitter stocktwits trandingview |
Health Technology
| | O: -0.1% H: 0.85% C: -2.15%
ABUS | $2.99 2.75% 2.68% 3.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.4% H: 2.8% C: 2.0%

update financial results
Arbutus to Report First Quarter 2023 Financial Results and Provide Corporate Update
Published: 2023-04-20 (Crawled : 12:20) - biospace.com/
ABUS | $2.99 2.75% 2.68% 3.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.33% H: 0.33% C: -1.0%

report update financial results
Vaccitech Reports Full-Year 2022 Financial Results and an Update on Corporate Developments
Published: 2023-03-24 (Crawled : 12:20) - globenewswire.com
ABUS | $2.99 2.75% 2.68% 3.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.34% H: 2.03% C: 1.69%

update financial results
Arbutus Reports Fourth Quarter and Year End 2022 Financial Results and Corporate Update
Published: 2023-03-02 (Crawled : 14:00) - biospace.com/
ABUS | $2.99 2.75% 2.68% 3.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.0% C: 0.0%

year financial update results
Arbutus to Report Fourth Quarter and Year End 2022 Financial Results and Provide Corporate Update
Published: 2023-02-16 (Crawled : 13:00) - globenewswire.com
ABUS | $2.99 2.75% 2.68% 3.6M twitter stocktwits trandingview |
Health Technology
| | O: -1.47% H: 1.49% C: -1.12%

report year financial update results
Arbutus Announces 2023 Corporate Objectives and Provides Financial Update
Published: 2023-01-05 (Crawled : 14:20) - biospace.com/
ABUS | $2.99 2.75% 2.68% 3.6M twitter stocktwits trandingview |
Health Technology
| | O: -1.33% H: 2.24% C: 1.35%

financial update
Arbutus Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-11-09 (Crawled : 13:00) - biospace.com/
ASMB | $14.91 1.78% 1.74% 17K twitter stocktwits trandingview |
Health Technology
| | O: -1.46% H: 2.22% C: -2.96%
ABUS | $2.99 2.75% 2.68% 3.6M twitter stocktwits trandingview |
Health Technology
| | O: -4.88% H: 9.19% C: 4.27%

financial update results
Arbutus to Report Third Quarter 2022 Financial Results and Provide Corporate Update
Published: 2022-10-26 (Crawled : 12:00) - globenewswire.com
ABUS | $2.99 2.75% 2.68% 3.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.46% H: 6.02% C: 4.17%

report financial update results
Arbutus Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-08-04 (Crawled : 12:00) - biospace.com/
ROIV | $10.85 -0.82% -0.83% 4.7M twitter stocktwits trandingview |
Manufacturing
| | O: 1.32% H: 0.26% C: -1.04%
ASMB | $14.91 1.78% 1.74% 17K twitter stocktwits trandingview |
Health Technology
| | O: 1.44% H: 3.08% C: 1.42%
ABUS | $2.99 2.75% 2.68% 3.6M twitter stocktwits trandingview |
Health Technology
| | O: 1.63% H: 2.4% C: 1.6%

update results
Arbutus to Report Second Quarter 2022 Financial Results and Provide Corporate Update
Published: 2022-07-21 (Crawled : 12:00) - globenewswire.com
ABUS | $2.99 2.75% 2.68% 3.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.78% H: 1.96% C: 1.18%

report update results
Arbutus Biopharma Provides Update on the Phase 2A Combination Trial with AB-729 and a Capsid Inhibitor
Published: 2022-07-20 (Crawled : 21:00) - biospace.com/
ABUS | $2.99 2.75% 2.68% 3.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.4% H: 5.56% C: 1.98%

ab-729 biopharma trial update phase 2b
Arbutus Presents New Data on AB-729, AB-836 and AB-101 at the EASL International Liver Congress™ 2022 and Provides AB-836 Clinical Update
Published: 2022-06-25 (Crawled : 08:20) - globenewswire.com
ABUS | $2.99 2.75% 2.68% 3.6M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

ab-729 liver update international
Gainers vs Losers
49% 51%

Top 10 Gainers
KAVL | $6.275 135.02% 57.45% 44M twitter stocktwits trandingview |
Wholesale Trade

PXMD | $0.7375 79.09% 44.16% 4.5M twitter stocktwits trandingview |
Health Technology

DYNT | $0.371 -5.12% 43.09% 3.3M twitter stocktwits trandingview |
Health Technology

LGVN P 3 d | $2.94 73.96% 42.52% 57M twitter stocktwits trandingview |

HUBC | $1.94 49.23% 32.99% 73M twitter stocktwits trandingview |
n/a

SPCB | $0.4044 46.52% 31.75% 130M twitter stocktwits trandingview |
Electronic Technology

ONVO | $1.34 32.66% 24.62% 54M twitter stocktwits trandingview |
Health Technology

OMQS | $0.6869 32.1% 24.3% 3.6M twitter stocktwits trandingview |
Professional, Scientific, and T...

SNPO | $10.555 29.67% 22.88% 4M twitter stocktwits trandingview |

AMBI | $3.72 -26.77% 21.77% 9.8K twitter stocktwits trandingview |
n/a


Your saved searches
Save your searches and get alerts when important news are released.